Literature DB >> 23483859

Fibroscan (transient elastography) for the measurement of liver fibrosis.

Nezam H Afdhal1.   

Abstract

Entities:  

Year:  2012        PMID： 23483859      PMCID： PMC3594956     

Source DB:  PubMed          Journal:  Gastroenterol Hepatol (N Y)        ISSN： 1554-7914


× No keyword cloud information.
  9 in total

1.  Editorial: staging liver fibrosis in hepatitis C: a challenge for this decade.

Authors:  Michelle Lai; Nezam H Afdhal
Journal:  Am J Gastroenterol       Date:  2011-12       Impact factor: 10.864

2.  The optimal cut-off for predicting large oesophageal varices using transient elastography is disease specific.

Authors:  S Pritchett; A Cardenas; D Manning; M Curry; N H Afdhal
Journal:  J Viral Hepat       Date:  2010-10-07       Impact factor: 3.728

3.  Prospective comparison of transient elastography, Fibrotest, APRI, and liver biopsy for the assessment of fibrosis in chronic hepatitis C.

Authors:  Laurent Castéra; Julien Vergniol; Juliette Foucher; Brigitte Le Bail; Elise Chanteloup; Maud Haaser; Monique Darriet; Patrice Couzigou; Victor De Lédinghen
Journal:  Gastroenterology       Date:  2005-02       Impact factor: 22.682

4.  Transient elastography for predicting clinical outcomes in patients with chronic liver disease.

Authors:  D A Klibansky; S H Mehta; M Curry; I Nasser; T Challies; N H Afdhal
Journal:  J Viral Hepat       Date:  2011-07-01       Impact factor: 3.728

Review 5.  Ultrasound-based hepatic elastography: origins, limitations, and applications.

Authors:  Eric B Cohen; Nezam H Afdhal
Journal:  J Clin Gastroenterol       Date:  2010-10       Impact factor: 3.062

6.  Comparison of transient elastography, serum markers and clinical signs for the diagnosis of compensated cirrhosis.

Authors:  Raza Malik; Michelle Lai; Amama Sadiq; Rory Farnan; Shruti Mehta; Imad Nasser; Tracy Challies; Detlef Schuppan; Nezam Afdhal
Journal:  J Gastroenterol Hepatol       Date:  2010-09       Impact factor: 4.029

7.  Noninvasive assessment of liver fibrosis by measurement of stiffness in patients with chronic hepatitis C.

Authors:  Marianne Ziol; Adriana Handra-Luca; Adrien Kettaneh; Christos Christidis; Frédéric Mal; Farhad Kazemi; Victor de Lédinghen; Patrick Marcellin; Daniel Dhumeaux; Jean-Claude Trinchet; Michel Beaugrand
Journal:  Hepatology       Date:  2005-01       Impact factor: 17.425

8.  Validation of hepascore, compared with simple indices of fibrosis, in patients with chronic hepatitis C virus infection in United States.

Authors:  Laren Becker; Wael Salameh; Anthony Sferruzza; Ke Zhang; Ro ng Chen; Raza Malik; Richard Reitz; Imad Nasser; Nezam H Afdhal
Journal:  Clin Gastroenterol Hepatol       Date:  2009-06       Impact factor: 11.382

Review 9.  Diagnosis and quantitation of fibrosis.

Authors:  Diarmuid S Manning; Nezam H Afdhal
Journal:  Gastroenterology       Date:  2008-05       Impact factor: 22.682
  9 in total
  26 in total

Review 1.  Clinical Laboratory Testing in the Era of Directly Acting Antiviral Therapies for Hepatitis C.

Authors:  Eleanor M Wilson; Elana S Rosenthal; Sarah Kattakuzhy; Lydia Tang; Shyam Kottilil
Journal:  Clin Microbiol Rev       Date:  2016-10-19       Impact factor: 26.132

Review 2.  A comprehensive review of noninvasive liver fibrosis tests in pediatric nonalcoholic Fatty liver disease.

Authors:  Sana Mansoor; Elizabeth Collyer; Naim Alkhouri
Journal:  Curr Gastroenterol Rep       Date:  2015-06

Review 3.  An Interaction Between Glecaprevir, Pibrentasvir, and Colchicine Causing Rhabdomyolysis in a Patient With Chronic Renal Disease.

Authors:  Dawn S Harrison; Jane Giang; Jama M Darling
Journal:  Clin Liver Dis (Hoboken)       Date:  2020-02-25

Review 4.  Non-alcoholic fatty liver disease in 2015.

Authors:  Monjur Ahmed
Journal:  World J Hepatol       Date:  2015-06-18

Review 5.  Transient elastography (FibroScan(®)) with controlled attenuation parameter in the assessment of liver steatosis and fibrosis in patients with nonalcoholic fatty liver disease - Where do we stand?

Authors:  Ivana Mikolasevic; Lidija Orlic; Neven Franjic; Goran Hauser; Davor Stimac; Sandra Milic
Journal:  World J Gastroenterol       Date:  2016-08-28       Impact factor: 5.742

Review 6.  Senescence in hepatic stellate cells as a mechanism of liver fibrosis reversal: a putative synergy between retinoic acid and PPAR-gamma signalings.

Authors:  Concetta Panebianco; Jude A Oben; Manlio Vinciguerra; Valerio Pazienza
Journal:  Clin Exp Med       Date:  2016-09-21       Impact factor: 3.984

7.  Use of carnosine in the prevention of cardiometabolic risk factors in overweight and obese individuals: study protocol for a randomised, double-blind placebo-controlled trial.

Authors:  Kirthi Menon; James D Cameron; Maximilian de Courten; Barbora de Courten
Journal:  BMJ Open       Date:  2021-05-13       Impact factor: 2.692

8.  The frequency and determinants of liver stiffness measurement failure: a retrospective study of "real-life" 38,464 examinations.

Authors:  Dong Ji; Qing Shao; Ping Han; Fan Li; Bing Li; Hong Zang; Xiaoxia Niu; Zhongbin Li; Shaojie Xin; Guofeng Chen
Journal:  PLoS One       Date:  2014-08-14       Impact factor: 3.240

9.  Using vibration controlled transient elastography and FIB-4 to assess liver cirrhosis in a hepatitis C virus infected population.

Authors:  Nabil Saleem; Lesley S Miller; Alia S Dadabhai; Emily J Cartwright
Journal:  Medicine (Baltimore)       Date:  2021-06-11       Impact factor: 1.817

10.  Elevated red cell distribution width is associated with advanced fibrosis in NAFLD.

Authors:  Hwa Mok Kim; Bum Soo Kim; Yong Kyun Cho; Byung Ik Kim; Chong Il Sohn; Woo Kyu Jeon; Hong Joo Kim; Dong Il Park; Jung Ho Park; Kwan Joong Joo; Chang Joon Kim; Yong Sung Kim; Woon Je Heo; Won Seok Choi
Journal:  Clin Mol Hepatol       Date:  2013-09-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.